INS and autoimmune polyendocrinopathy: At baseline, no differences between groups A and B were observed with regard to diabetes complications, type of APS, smoking, central obesity, hypercholesterolemia, low HDL, duration of diabetes, total daily, basal and mealtime insulin doses and HbA1c (Table 1).